Abstract PS5-11-12: Economic Impact of Adverse Event Management in HR+/HER2− Metastatic Breast Cancer: A Comparative Analysis of Datopotamab deruxtecan and standard of care in the Brazilian Private Healthcare System
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: H. T. dos Santos, T. B. de Oliveira, A. B. Villa, C. d. Huerta, L. dos Santos, F. d. Costa, G. L. V. Araujo
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W7129478521
Cites:
Cited by:
Related to:
